News | March 30, 2008

Study Finds PCI Safe, Effective Despite Off-Site Cardiac Surgery

March 31, 2008 - Percutaneous coronary intervention (PCI) can be performed safely and successfully in medical centers without on-site cardiac surgical back-up, provided programs are well-organized, highly skilled and committed to quality. These are the findings of the largest clinical study ever to compare PCI programs that have on-site cardiac surgery to PCI programs that transfer patients to a surgical hospital in case of emergency.

The study was reported today in a Late-Breaking Clinical Trials session at the SCAI Annual Scientific Sessions in Partnership with ACC i2 Summit (SCAI-ACCi2) in Chicago. SCAI-ACCi2 is a scientific meeting for practicing cardiovascular interventionalists sponsored by the Society for Cardiovascular Angiography and Interventions (SCAI) in partnership with the American College of Cardiology (ACC).
The study’s findings, though reassuring, should not be interpreted as an endorsement of “boutique” angioplasty, said lead investigator Michael A. Kutcher, MD, director of interventional cardiology at Wake Forest University Health Sciences, Winston-Salem, NC.

“These medical centers are very accomplished and represent the premier programs offering PCI with off-site cardiac surgical back-up,” Dr. Kutcher said. “And they are doing angioplasty for the right reasons: to improve outcomes for heart attack patients and to better serve patients in remote geographic areas.”

Performing PCI at medical centers with off-site cardiac surgical back-up is controversial. Clinical guidelines accept this practice for patients who are experiencing a heart attack—so-called primary PCI—but advise against it in elective PCI, when the procedure is less urgent. However, medical centers that offer primary PCI argue they need to include elective PCI in the mix in order to survive economically and to keep staff skill levels high. Further complicating the issue: Emergency bypass surgery is rare—it’s needed in about 0.3 percent of PCI patients—but the mortality rate is high, about 13 percent.

For the new study, Dr. Kutcher and co-investigators analyzed data from the NCDR CathPCI Registry (an ACC initiative conducted in partnership with SCAI) on 9,029 patients treated at 61 medical centers with off-site cardiac surgical back-up and 299,132 patients treated at 404 medical centers with on-site cardiac surgery programs. Programs with off-site surgical back-up tended to be smaller—more than half of the medical centers had fewer than 200 beds—and to perform fewer PCIs. Only 30 percent of off-site programs performed more than 200 PCI procedures annually, and only 43 percent performed more than 36 primary PCIs annually, as compared with 94 percent and 80 percent of on-site centers, respectively (p

Still, the two types of hospitals had similar rates of procedural success (94 percent for off-site centers vs. 93 percent for on-site centers), overall complications (6.4 percent vs. 6.3 percent, respectively), emergency surgery (0.31 percent vs. 0.37 percent), and mortality with emergency surgery (13.64 percent vs. 12.59 percent). In a risk-adjusted analysis, hospitals with on-site cardiac surgery were more likely to perform emergency bypass surgery, but overall in-hospital mortality was no different in the two groups (odds ratio, 1.08 for on-site vs. off-site centers, p=0.507).

That the hospitals in this study voluntarily chose to submit data to the NCDR is one sign of their commitment to quality, Dr. Kutcher said. Two additional statistics are telling: 92 percent of PCI centers with off-site surgery were prepared to do PCI 24 hours a days, seven days a week, and when treating patients with heart attack, the time from patient arrival at the hospital until blood flow was restored in the coronary artery was a median of 1.4 hours at hospitals with off-site surgical back-up, as compared with 1.5 hours for PCI centers with on-site surgery.

“The NCDR database provided an excellent opportunity to look at contemporary angioplasty practice patterns in the U.S. The safety and effectiveness of PCI programs with off-site cardiac surgery is a very important question, and we need ongoing information to reach evidence-based answers,” Dr. Kutcher said. “However, the results of this study should not be used to encourage the wild expansion of more off-site PCI programs; rather they should be used to confirm the appropriateness of this strategy for programs that have made a strong commitment to excellent organization and data submission for quality assurance.”
For more information: www.acc08.org

Related Content

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp
Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Cardiovascular Clinical Studies | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo
Lexington Begins HeartSentry Clinical Trial
News | Cardiovascular Clinical Studies | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Cardiovascular Clinical Studies | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Cardiovascular Clinical Studies | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Cardiovascular Clinical Studies | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
stroke risk
News | Cardiovascular Clinical Studies | August 28, 2015
Most people assume strokes only happen to octogenarians, but recent evidence suggests that survivors of childhood can
Overlay Init